Vivosonic

Vivosonic operates in the medical-device and health-diagnostics segments, focused on audiology, newborn hearing screening, and auditory measurement. Its product range combines auditory evoked potential testing, otoacoustic emissions measurement, and vestibular testing capabilities. The Integrity V500 System and Awake ABR distinguish the offering through support for testing without sedation, while VivoLink Wireless Technology enables untethered testing and Amplitrode is designed to amplify and filter electrophysiological signals at the recording site. The company also emphasizes use in electrically noisy clinical environments and distribution in more than 55 countries. These characteristics point to a specialist clinical-equipment position rather than a broad general-purpose medical-device portfolio. Its apparent differentiation is therefore best assessed through product attributes: awake testing, wireless operation, signal-quality features, and coverage across several auditory diagnostic methods.

Vivosonic was founded in 1999 and has an established product portfolio spanning the Integrity V500 System, Awake ABR, VivoLink Wireless Technology, and Amplitrode. The company's product development appears focused on improving the practicality of auditory testing: Awake ABR supports testing without sedation, VivoLink provides wireless operation, and Amplitrode is intended to improve electrophysiological signal quality. The company is classified in the 11–50 employee range, and hiring information indicates permanent, full-time roles in Toronto without specifying job functions. As a result, the strongest visible indicators of trajectory are the breadth of the product lineup, its international distributor reach, and continued hiring activity.